Decreased protein S activity in sickle cell disease.
In sickle cell disease (SCD), vaso-occlusion is a complex process involving cellular, vascular and humoral factors and possibly thrombotic events. We studied three physiological inhibitors of the coagulation system, antithrombin III (AT III), protein C (PC) and protein S (PS), in three groups of subjects: 27 homozygous patients observed either in crisis or in a steady state, 23 heterozygous patients and 30 healthy subjects. PS study included the measurement of total and free PS antigen, PS activity and C4bBP antigen. In heterozygous subjects the results were similar to those of controls, but in homozygous subjects abnormalities of PS and to a lesser extent PC were observed. Values of PC were extremely variable with 10 cases lower than the normal range (2 SD of the mean) and 17 others within this range. In all cases total PS antigen was slightly reduced (77 +/- 18%, M +/- SD) with a more marked decrease of free antigen (59 +/- 17%) and normal values of C4bBP. Levels of PS activity were greatly reduced and lower than those of free antigen with a mean ratio of PS activity to free antigen of 0.6. These abnormalities were associated with significantly high concentrations of fibrinogen D-dimers. PS deficiency in SCD may be at least partly due to adsorption of free PS to aminophospholipids abnormally expressed on sickle cells membranes, microvesicles and activated platelets, while the discrepancy between PS activity and free antigen could reflect proteolytic inactivation of PS by traces of thrombin.
Marfaing-Koka
A
A
Laboratoire d'Hématologie, Hôpital Bicêtre, Le Kremlin, France.
Boyer-Neumann
C
C
Wolf
M
M
Leroy-Matheron
C
C
Cynober
T
T
Tchernia
G
G
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood* / Q000235:genetics; D000941:Antigens / Q000097:blood; D000990:Antithrombin III / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D015935:Complement C4b; D003169:Complement Inactivator Proteins; D004730:Endothelium, Vascular / Q000502:physiology; D005260:Female; D006023:Glycoproteins; D006720:Homozygote; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000502:physiology; D011486:Protein C / Q000378:metabolism*; D017293:Protein S / Q000097:blood* / Q000276:immunology; D011951:Receptors, Complement / Q000378:metabolism
D000941:Antigens; D002352:Carrier Proteins; D003169:Complement Inactivator Proteins; D006023:Glycoproteins; D011486:Protein C; D017293:Protein S; D011951:Receptors, Complement; D015935:Complement C4b; D000990:Antithrombin III